Bruker Corporation has announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-content microscopy. This acquisition adds high-performance on-premise processing, secure storage and networking technology that complements Bruker’s advanced fluorescence microscopy imaging products, such as light-sheet and super-resolution microscopy products, which generate high information content...

As part of its efforts to support emerging biotechnology companies with addressing key challenges of bringing new therapies to market, Thermo Fisher Scientific has announced it has become a founding sponsor of Momentum Labs in Alachua, Fla. Momentum Labs will serve as a collaborative laboratory and office space for growing biotech businesses in the greater Gainesville region...

PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, and ThinkCyte K.K, a biotechnology company pioneering novel cell analysis and sorting instruments, has announced a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence (AI)...

Agilent Technologies Inc. has announce that the U.S. Food and Drug Administration (FDA) has approved Agilent Resolution ctDx FIRST as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients with KRAS G12C mutations who may benefit from treatment with KRAZATI^TM (adagrasib). This is the first liquid biopsy NGS assay approved by the FDA as a CDx for the newly approved KRAZATI in advanced NSCLC and was developed in collaboration with Mirati Therapeutics...

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces a selection of new contract wins where Optimer technology is being explored by partners to offer new strategies for therapeutics and potentially offer improved assay sensitivity and selectivity over antibodies. Optimer binders are oligonucleotide-based affinity ligands generated through the in vitro Optimer platform, which can be used as antibody alternatives...

Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, announce the launch of its High Throughput Screening (HTS) capability, as well as the expansion of its state-of-the-art lab and office facilities. Scott Maidment has been appointed as Head of HTS to lead the new service...

Whole-genome sequencing of 35,000 de-identified, diverse genomic DNA samples will begin this month. Illumina Inc., a global leader in DNA sequencing and array-based technologies, and Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), have announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples...

This strategic acquisition, which follows a long-standing relationship of almost a decade, will allow Astrea Bio to expand its product offering to include a full range of high-performance chromatography columns for biomanufacturing, complementing and strengthening the company’s existing portfolio of bioprocessing resins, reusable columns, and prepacked single-use columns...

Bruker Corporation and Switzerland-based Biognosys AG have announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys. New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics...

The life science group Sartorius extended a strategic collaboration partnership agreement with RoosterBio Inc. (RoosterBio) to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies. Through this collaboration, Sartorius and RoosterBio will provide best-in-class solutions and expertise for a human mesenchymal stem/stromal cell (hMSC) - based exosome production platform that delivers industry-leading yield, purity, and potency...

Sally-Anne Whybrow, Healthcare Business Development Manager, Siemens Financial Services, UK explains why CROs are turning to smart finance solutions from specialist financiers. For more than twenty years the trend of outsourcing R&D activities in the pharmaceutical industry has been gaining traction. Driven by the need for continued innovation, outsourcing to a Contract Research Organisation (CRO) has now become a mainstay for pharmaceutical, biotechnology and biomed companies of all sizes...

Scientific Laboratory Supplies (SLS) the leading supplier of equipment, chemicals and consumables for laboratory use in the UK – are excited to announce the acquisition of C&M Scientific, a Scotland-based distributor of laboratory equipment and service provider specialising in installation, validation, calibration, repair and ongoing maintenance for scientific equipment...

BioGrad is to open the UK's second largest biobank facility in Liverpool, as part of a £7.6m investment into a new headquarters at Wavertree Technology Park. In collaboration with the University of Leicester, BioGrad biobank has already welcomed up to 261,000 samples from the largest long-Covid study in the UK. Further partnerships with Liverpool Women’s Hospital and three private research companies will see BioGrad bank over one million human cell samples banked in its first year...

Staying ahead of the competition with INTEGRA Biosciences’ pipettes. Students of Technische Universität Braunschweig, Germany, used INTEGRA Biosciences’ VIAFLO electronic pipettes and EVOLVE manual pipettes to perform sample transfers and dilutions as part of their project for the 2022 iGEM competition. The pipettes helped the team to speed up liquid handling and increase pipetting accuracy, giving the students a competitive edge over their peers...

The Medical Research Council’s new home for its London Institute of Medical Sciences (LMS) has reached practical completion. Credited with many life-changing discoveries, the new 12,500m2 building will accommodate over 40 research groups for the first time in a single ultramodern space to enhance collaboration and its research...

Cherwell, specialists in cleanroom microbiology solutions for the pharmaceutical, healthcare and related industries, will be exhibiting and discussing the latest additions to its high-quality range of environmental monitoring (EM) products at thePharmaceutical Microbiology Europe Conference, in London, 16-17 January 2023. This is the first time that Cherwell will attend this annual conference...

The funding will enable research which could deliver world-leading genomic healthcare to patients, which involves the study of people’s DNA. The boost is part of a new three-year plan to develop, evaluate and roll out new technologies across the health and care system and life sciences sector, bolstering the UK’s position as a life sciences superpower...

The parent company behind Edulab and SciChem is evolving as part of its strategic growth plans. Inivos Scientific Ltd, the parent company behind Edulab and Science & Chemical Supplies (SciChem), announces a rebranding and restructuring of the business to reflect its evolution and strategic growth plans. As of 3rd January 2023, VITTA Group will consist of four core divisions and a developing brand portfolio...

Integrated DNA Technologies, Inc. (IDT) has announced it closed on the purchase of Next Generation Sequencing (NGS) research assays from Invitae Corporation under the trademarked name Archer®. The integration of IDT’s portfolio with the acquired NGS research assays—which have been foundational in researching novel cancer fusions—will empower labs with an all-in-one solution to uncover biomarkers and advance cancer discoveries...